About

Cortney Inman is an associate in the Governmental Practice Group in the firm's Washington, D.C. office and a member of the FDA Regulatory and Life…

Cortney Inman is an associate in the Governmental Practice Group in the firm's Washington, D.C. office and a member of the FDA Regulatory and Life Sciences teams.

Latest Post

In the Law360 article “Key Takeaways From FDA’s Latest Social Media Warnings,” Sheppard Mullin FDA Regulatory attorneys Dominick DiSabatino, Cortney Inman and law clerk Julian Klein cover the FDA’s Office of Prescription Drug Promotion October 31 untitled letter to Merz Pharmaceuticals GmbH regarding the social media promotion of Xeomin, an injectable for improving glabellar lines. The FDA critiqued the video on Xeomin’s Instagram account, noting misleading risk and efficacy presentations.

Continue Reading Key Takeaways from FDA’s Latest Social Media Warnings

About

Cortney Inman is an associate in the Governmental Practice Group in the firm's Washington, D.C. office and a member of the FDA Regulatory and Life…

Cortney Inman is an associate in the Governmental Practice Group in the firm's Washington, D.C. office and a member of the FDA Regulatory and Life Sciences teams.

Subscribe: Subscribe via RSS